From Techstars Picks 9 Startups For Seattle, Complementing Local Strengths:

Seattle sunset via Flickr—

Downtown Seattle by Flickr user Tiffany Von Arnim, cropped and used under a Creative Commons License. https://flic.kr/p/pNyDuA
https://creativecommons.org/licenses/by/2.0/

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
Biopharma and Tech Innovators Summer 2020
The cutting-edge companies behind the innovations disrupting biopharma and revolutionizing the healthcare landscape

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine

BioNTech's mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity

Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data

CSL Behring Bolsters Hemophilia Lineup With Deal for uniQure’s Gene Therapy

Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better

MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy

On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO

Alpine Immune Sciences Lands AbbVie as R&D Partner for Lupus Drug

Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later

Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage

Akili Interactive’s Video Game for ADHD Gets the FDA All Clear

Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs

The 2020 National Xconomy Awards

Xcelerating Life Sciences Seattle

Xcelerating Life Sciences New York

From Techstars Picks 9 Startups For Seattle, Complementing Local Strengths:

Underwriters and Partners

Biopharma and Tech Innovators Summer 2020

How Big Is the US Market for Medical Devices & Technologies?

What’s Next in Neuroscience Therapies

Xconomy on Demand

We offer a number of ways to subscribe for free!